Automated microfluidic cell culture of stem cell derived dopaminergic neurons.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
11 02 2019
Historique:
received: 05 01 2018
accepted: 12 10 2018
entrez: 12 2 2019
pubmed: 12 2 2019
medline: 22 9 2020
Statut: epublish

Résumé

Parkinson's disease is a slowly progressive neurodegenerative disease characterised by dysfunction and death of selectively vulnerable midbrain dopaminergic neurons and the development of human in vitro cellular models of the disease is a major challenge in Parkinson's disease research. We constructed an automated cell culture platform optimised for long-term maintenance and monitoring of different cells in three dimensional microfluidic cell culture devices. The system can be flexibly adapted to various experimental protocols and features time-lapse imaging microscopy for quality control and electrophysiology monitoring to assess cellular activity. Using this system, we continuously monitored the differentiation of Parkinson's disease patient derived human neuroepithelial stem cells into midbrain specific dopaminergic neurons. Calcium imaging confirmed the electrophysiological activity of differentiated neurons and immunostaining confirmed the efficiency of the differentiation protocol. This system is the first example of an automated Organ-on-a-Chip culture and has the potential to enable a versatile array of in vitro experiments for patient-specific disease modelling.

Identifiants

pubmed: 30741972
doi: 10.1038/s41598-018-34828-3
pii: 10.1038/s41598-018-34828-3
pmc: PMC6370836
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1796

Références

Drug Discov Today. 2000 Dec 1;5(12 Suppl 1):84-91
pubmed: 11564571
Proc Natl Acad Sci U S A. 2005 Mar 8;102(10):3840-5
pubmed: 15738408
Int J Biochem Cell Biol. 2005 May;37(5):942-6
pubmed: 15743669
Stem Cells. 2005 Jun-Jul;23(6):781-90
pubmed: 15917474
Biotechnol Bioeng. 2007 Jan 1;96(1):195-201
pubmed: 16960892
Stud Health Technol Inform. 2006;124:133-8
pubmed: 17108516
PLoS Pathog. 2007 Jul;3(7):e99
pubmed: 17658948
Anal Chem. 2007 Nov 15;79(22):8557-63
pubmed: 17953452
Cell. 2007 Nov 30;131(5):861-72
pubmed: 18035408
Biotechnol Bioeng. 2009 Apr 15;102(6):1636-44
pubmed: 19062183
Lancet. 2009 Jun 13;373(9680):2055-66
pubmed: 19524782
Science. 2010 Jun 25;328(5986):1662-8
pubmed: 20576885
Lab Chip. 2011 May 7;11(9):1596-602
pubmed: 21394334
Nat Methods. 2011 May 22;8(7):581-6
pubmed: 21602799
BMC Bioinformatics. 2011 Jun 08;12:230
pubmed: 21651810
J Lab Autom. 2011 Oct;16(5):371-6
pubmed: 21906563
Plant Cell. 2011 Dec;23(12):4234-40
pubmed: 22186371
Anal Chem. 2012 Feb 21;84(4):1840-8
pubmed: 22242722
J Lab Autom. 2012 Apr;17(2):86-95
pubmed: 22357556
J Lab Autom. 2012 Jun;17(3):169-85
pubmed: 22357568
PLoS One. 2012;7(7):e41120
pubmed: 22815935
Parkinsons Dis. 2012;2012:920953
pubmed: 22966478
Anal Chem. 2012 Nov 6;84(21):9446-52
pubmed: 23004687
J Biol Chem. 2013 Apr 12;288(15):10736-41
pubmed: 23086948
Proc Natl Acad Sci U S A. 2013 Jan 2;110(1):129-34
pubmed: 23251032
J Lab Autom. 2013 Aug;18(4):328-33
pubmed: 23413273
FEBS Lett. 2013 Apr 17;587(8):1139-46
pubmed: 23458259
PLoS One. 2013;8(3):e59252
pubmed: 23533608
Lab Chip. 2013 Sep 21;13(18):3548-54
pubmed: 23887749
BMC Biotechnol. 2013 Nov 15;13:102
pubmed: 24228851
J Biotechnol. 2014 Mar 10;173:53-8
pubmed: 24440272
Nat Commun. 2014 Jun 06;5:4028
pubmed: 24905578
Biosens Bioelectron. 2015 Jan 15;63:218-231
pubmed: 25105943
Curr Opin Biotechnol. 2015 Feb;31:79-85
pubmed: 25232996
Exp Gerontol. 2015 Aug;68:33-8
pubmed: 25261764
Lab Chip. 2015 Jun 7;15(11):2419-28
pubmed: 25902196
Curr Opin Biotechnol. 2015 Dec;35:118-26
pubmed: 26094109
Nat Methods. 2015 Sep;12(9):885-92
pubmed: 26237226
Sci Rep. 2015 Nov 17;5:16647
pubmed: 26573336
Clin Microbiol Infect. 2016 Mar;22(3):236-43
pubmed: 26577142
Neuropathol Appl Neurobiol. 2016 Feb;42(1):77-94
pubmed: 26613567

Auteurs

Khalid I W Kane (KIW)

Luxembourg Centre for Systems Biomedicine, University of Luxembourg, 7 avenue des Hauts-Fourneaux, L-4362, Esch-sur-Alzette, Luxembourg.

Edinson Lucumi Moreno (EL)

Luxembourg Centre for Systems Biomedicine, University of Luxembourg, 7 avenue des Hauts-Fourneaux, L-4362, Esch-sur-Alzette, Luxembourg.
Division of Systems Biomedicine and Pharmacology, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333CC, Leiden, The Netherlands.

Siham Hachi (S)

Luxembourg Centre for Systems Biomedicine, University of Luxembourg, 7 avenue des Hauts-Fourneaux, L-4362, Esch-sur-Alzette, Luxembourg.

Moriz Walter (M)

Fraunhofer Institute for Manufacturing Engineering and Automation IPA, Stuttgart, Germany.

Javier Jarazo (J)

Luxembourg Centre for Systems Biomedicine, University of Luxembourg, 7 avenue des Hauts-Fourneaux, L-4362, Esch-sur-Alzette, Luxembourg.

Miguel A P Oliveira (MAP)

Luxembourg Centre for Systems Biomedicine, University of Luxembourg, 7 avenue des Hauts-Fourneaux, L-4362, Esch-sur-Alzette, Luxembourg.

Thomas Hankemeier (T)

Division of Systems Biomedicine and Pharmacology, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333CC, Leiden, The Netherlands.

Paul Vulto (P)

Mimetas B.V, PO Box 11002, 2301EA, Leiden, The Netherlands.

Jens C Schwamborn (JC)

Luxembourg Centre for Systems Biomedicine, University of Luxembourg, 7 avenue des Hauts-Fourneaux, L-4362, Esch-sur-Alzette, Luxembourg.

Martin Thoma (M)

Fraunhofer Institute for Manufacturing Engineering and Automation IPA, Stuttgart, Germany.

Ronan M T Fleming (RMT)

Luxembourg Centre for Systems Biomedicine, University of Luxembourg, 7 avenue des Hauts-Fourneaux, L-4362, Esch-sur-Alzette, Luxembourg. ronan.mt.fleming@gmail.com.
Division of Systems Biomedicine and Pharmacology, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333CC, Leiden, The Netherlands. ronan.mt.fleming@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH